News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
224,997 Results
Type
Article (5008)
Company Profile (17)
Press Release (219972)
Section
Business (82197)
Career Advice (461)
Deals (15041)
Drug Delivery (8)
Drug Development (19061)
Employer Resources (30)
FDA (3676)
Job Trends (3900)
News (120098)
Policy (7500)
Tag
2024 BioCapital Digital (2)
2024 Biotech Beach Standard (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
Academia (292)
Accelerated approval (2)
Adcomms (3)
Allergies (9)
Alliances (14765)
ALS (19)
Alzheimer's disease (247)
Antibody-drug conjugate (ADC) (11)
Approvals (3693)
Artificial intelligence (40)
Autoimmune disease (3)
Automation (2)
Bankruptcy (97)
Best Places to Work (2862)
Biosimilars (11)
Biotechnology (21)
Bladder cancer (9)
Brain cancer (7)
Breast cancer (48)
Cancer (438)
Cardiovascular disease (22)
Career advice (392)
Career pathing (2)
CAR-T (31)
Cell therapy (102)
Cervical cancer (2)
Clinical research (16014)
Collaboration (164)
Compensation (163)
Complete response letters (2)
COVID-19 (301)
CRISPR (7)
C-suite (99)
Cystic fibrosis (16)
Data (503)
Depression (5)
Diabetes (40)
Diagnostics (2039)
Digital health (3)
Diversity, equity & inclusion (12)
Drug discovery (15)
Drug pricing (6)
Drug shortages (1)
Duchenne muscular dystrophy (11)
Earnings (40775)
Editorial (2)
Employer branding (6)
Employer resources (31)
Events (37715)
Executive appointments (303)
FDA (3923)
Featured Employer (6)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (179)
Gene editing (15)
Generative AI (2)
Gene therapy (50)
GLP-1 (107)
Government (411)
Guidances (16)
Healthcare (5035)
Huntington's disease (1)
IgA nephropathy (4)
Immunology and inflammation (13)
Indications (6)
Infectious disease (317)
Inflammatory bowel disease (24)
Inflation Reduction Act (2)
Influenza (3)
Intellectual property (15)
Interviews (53)
IPO (7822)
IRA (3)
Job creations (1120)
Job search strategy (360)
Kidney cancer (6)
Labor market (4)
Layoffs (100)
Leadership (5)
Legal (2331)
Liver cancer (17)
Lung cancer (53)
Lymphoma (28)
Management (10)
Manufacturing (46)
MASH (27)
Medical device (3858)
Medtech (3859)
Mergers & acquisitions (7422)
Metabolic disorders (118)
Multiple sclerosis (8)
NASH (6)
Neurodegenerative disease (9)
Neuropsychiatric disorders (1)
Neuroscience (338)
NextGen: Class of 2025 (1674)
Non-profit (727)
Northern California (905)
Now hiring (2)
Obesity (52)
Opinion (30)
Ovarian cancer (17)
Pain (12)
Pancreatic cancer (14)
Parkinson's disease (26)
Partnered (4)
Patents (21)
Patient recruitment (27)
Peanut (5)
People (24564)
Pharmaceutical (5)
Pharmacy benefit managers (1)
Phase I (4773)
Phase II (6953)
Phase III (5544)
Pipeline (541)
Policy (8)
Postmarket research (625)
Preclinical (1868)
Press Release (66)
Prostate cancer (27)
Psychedelics (3)
Radiopharmaceuticals (105)
Rare diseases (67)
Real estate (1874)
Recruiting (8)
Regulatory (5110)
Reports (14)
Research institute (301)
Resumes & cover letters (68)
Rett syndrome (3)
Schizophrenia (21)
Series A (25)
Series B (22)
Sickle cell disease (7)
Southern California (686)
Special edition (1)
Spinal muscular atrophy (28)
Sponsored (3)
Startups (1007)
Stomach cancer (1)
Supply chain (10)
Tariffs (3)
United States (6903)
Vaccines (36)
Venture capitalists (2)
Weight loss (20)
Women's health (1)
Date
Today (5)
Last 7 days (122)
Last 30 days (734)
Last 365 days (10040)
2025 (2819)
2024 (11027)
2023 (13193)
2022 (18658)
2021 (19678)
2020 (18238)
2019 (13205)
2018 (10205)
2017 (10001)
2016 (9156)
2015 (12118)
2014 (9587)
2013 (7707)
2012 (8329)
2011 (8796)
2010 (8634)
Location
Africa (184)
Alabama (13)
Alaska (2)
Arizona (59)
Arkansas (1)
Asia (11441)
Australia (1606)
California (1898)
Canada (688)
China (70)
Colorado (80)
Connecticut (91)
Delaware (29)
Europe (24481)
Florida (267)
Georgia (33)
Idaho (23)
Illinois (111)
India (6)
Indiana (62)
Iowa (1)
Japan (67)
Kansas (24)
Kentucky (10)
Louisiana (5)
Maine (40)
Maryland (218)
Massachusetts (1527)
Michigan (85)
Minnesota (137)
Mississippi (1)
Missouri (21)
Montana (16)
Nebraska (12)
Nevada (23)
New Hampshire (15)
New Jersey (553)
New Mexico (5)
New York (466)
North Carolina (321)
North Dakota (2)
Northern California (905)
Ohio (55)
Oklahoma (5)
Oregon (3)
Pennsylvania (338)
Puerto Rico (1)
Rhode Island (12)
South America (276)
South Carolina (4)
Southern California (686)
Tennessee (38)
Texas (221)
Utah (59)
Virginia (43)
Washington D.C. (9)
Washington State (169)
West Virginia (2)
Wisconsin (21)
224,997 Results for "immucell corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ImmuCell Hires Chief Financial Officer
April 7, 2025
·
3 min read
Press Releases
ImmuCell Announces Initiation of Investigational Product Use of Re-Tain®
April 3, 2025
·
6 min read
Press Releases
ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2024
February 21, 2025
·
2 min read
Press Releases
ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2024
February 26, 2025
·
11 min read
Press Releases
ImmuCell Announces Settlement of Insurance Claim Related to Previously Disclosed Production Contamination Losses
January 16, 2025
·
5 min read
Business
ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2024
ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, today announced its unaudited financial results for the quarter ended March 31, 2024.
May 14, 2024
·
11 min read
BioForest
ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024
ImmuCell Corporation announced preliminary, unaudited sales results for the first quarter of 2024, which ended March 31, 2024.
April 9, 2024
·
6 min read
Press Releases
ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year 2024
January 10, 2025
·
6 min read
BioForest
ImmuCell Provides Update on Regulatory Status of Product Development Initiative for Re-Tain®
ImmuCell Corporation, a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, provided a regulatory update on the status of its product development initiative for Re-Tain®.
June 5, 2024
·
6 min read
Press Releases
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2024
November 7, 2024
·
2 min read
1 of 22,500
Next
